Glytec LLC

56 articles about Glytec LLC

• Major Academic Health System Taps Glytec for Insulin Management Technology

  6/29/2018

  Duke University Health System has selected Glytec’s eGlycemic Management System® to elevate the quality and safety of care for patients with diabetes and others who require insulin therapy.

• Glytec Adds Smart Meter to Growing Network of Connected Solution Partners

  6/6/2018

  For millions of patients with diabetes who’ve been unable to achieve their treatment goals, few programs have the potential to reduce A1C faster or more effectively than Glytec’s virtual insulin titration service.

• University of New Mexico Hospital to Bolster Patient Safety and Diabetes Care in Partnership with Glytec

  5/1/2018

  University of New Mexico Hospital is partnering with Glytec to achieve the highest levels of quality and safety for hospitalized patients who require insulin therapy.

• Two More Patent Allowances for Glytec’s Diabetes Software

  3/28/2018

  The latest allowances from the USPTO address systems and methods specific to the dosing of subcutaneous insulin for acute and chronic care.

• Glytec Announces Appointment of Ed Furlong as Chief Operating Officer

  3/21/2018

  Furlong joins the company during a period of extraordinary growth and will assume a key leadership role in scaling commercial operations to meet evolving customer needs.

• Glytec Release: Study Shows Computer-Guided Insulin Dosing Plus More Frequent Blood Glucose Testing Leads to Better Outcomes for Patients with Diabetes

  2/15/2018

  The authors concluded that Glytec’s Glucommander Outpatient delivered a statistically significant benefit to ALL study patients.

• Glytec’s Software Yields Superior Patient Outcomes According to Four New Studies in Journal of Diabetes Science and Technology

  1/23/2018

  Four new studies published in the January 2018 issue of Journal of Diabetes Science and Technology (JDST) demonstrate superior patient outcomes and organizational performance with Glytec’s eGlycemic Management System® (eGMS®) versus conventional, paper-based protocols.

• USPTO Grants Glytec Patent Allowance for Computer-Guided Selection and Dosing of All Diabetes Medications

  1/9/2018

  The patent allowance, issued by the United States Patent and Trademark Office, comprises an intricate series of 24 claims that describe personalized computer-guided selection and dosing of any prescribed diabetes therapy regimen, whether insulin only, non-insulin only or combination.

• Glytec Awarded Patent Allowance Supporting Connected Care Model for Insulin Management

  1/5/2018

  Glytec has been awarded another U.S. patent allowance for systems and methods related to insulin management in the outpatient environment.

• Glytec Integrates With Onduo Virtual Diabetes Clinic

  11/29/2017

  The integrated solution will launch in pilot programs with select U.S. providers and payers early 2018.

• Study Observed Improvements in Transitions of Care Using Hospital-to-Home Diabetes Therapy Management Software From Glytec

  11/8/2017

  The study observed that when providers used the Hospital-to-Home (H2H) module of Glytec’s eGlycemic Management System to guide insulin regimens prescribed at discharge, patients had no diabetes-related readmissions, urgent care visits or emergency department visits within the first 30 days.

• Adventist Health System Partners With Glytec To Enhance Diabetes Care

  10/17/2017

  More than a quarter of all hospitalized patients in the U.S. have diabetes, and typically, these patients stay longer, experience more infections and have higher readmission rates.

• Glytec Release: New Research Shows People On Insulin For Diabetes Maintain A1c Reductions Through Digital Therapy Management

  9/19/2017

• Glytec Nabs Fourth FDA 510(k) Clearance for Its Market-Leading Diabetes Therapy Management Software

  8/16/2017

• Glytec LLC Announces Fourth FDA 510(K) Clearance For Its Market-Leading Diabetes Therapy Management Software

  8/16/2017

• Glytec LLC Release: Presentation At AADE Conference Showcases Value Of Diabetes Decision Support Solutions

  8/8/2017

• Glytec LLC Receives Five Additional Patent Allowances For Its Diabetes Therapy Management Software

  6/30/2017

• AgaMatrix, Inc. And Glytec LLC Announce Partnership To Deliver A Cloud-Based Diabetes Management Platform To Improve Clinical Insights And Patient Blood Glucose Control

  6/9/2017

• Glytec LLC Release: Case Studies Presented At Diabetes Technology Society Conference Highlight Millions In Hospital Cost Savings With Improved Glucose Control

  6/7/2017

• Glytec LLC Release: Research Study From Emory University Observes $3,654 Per Patient Cost Savings For CABG Surgery

  4/26/2017